Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000899140-25-000997·Hinge Health, Inc.
Schedule 13G ownership disclosure
Hinge Health Inc
Class A Common Stock, par value $0.00001 per share · CUSIP: 433313103
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Insight Venture Partners X, LP
Shares: 5,508,113 · Class: 14.4%
- Insight Venture Partners (Cayman) X, LP
Shares: 4,516,719 · Class: 11.8%
- Insight Venture Partners (Delaware) X, LP
Shares: 873,715 · Class: 2.3%
- Insight Venture Partners X (Co-Investors), LP
Shares: 131,057 · Class: 0.3%
- Insight Venture Associates X, L.P.
Shares: 11,029,604 · Class: 28.8%
- Insight Venture Associates X, Ltd.
Shares: 11,029,604 · Class: 28.8%
- Insight Holdings Group, LLC
Shares: 11,029,604 · Class: 28.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-25-000997
- Form type
- SCHEDULE 13G
- Filer
- Hinge Health, Inc.
- CIK
- CIK 1673743
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership